Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisgender men and transgender women who have sex with men. We chara...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases Jg. 224; H. 9; S. 1581
Hauptverfasser:	Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 16.11.2021
Schlagworte:	Adolescent Adult Anti-HIV Agents - administration & dosage Diketopiperazines - administration & dosage Female HIV Infections - epidemiology HIV Infections - prevention & control HIV Integrase Inhibitors - administration & dosage Homosexuality, Male Humans Incidence Male Middle Aged Pre-Exposure Prophylaxis Pyridones - administration & dosage Retrospective Studies Transgender Persons Viral Load - drug effects injectable HIV preexposure prophylaxis HPTN 083 TDF/FTC cabotegravir long-acting men who have sex with men prevention
ISSN:	1537-6613, 1537-6613
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!